Dr. Joseph M. Bellapianta, MD

Dr. Bellapianta practices at Bellapianta Orthopaedics and Sports Medicine in Montclair, New Jersey.

Dr. Bellapianta's NPI, 1588823165, was assigned on June 9, 2008. Dr. Bellapianta graduated from Albany Medical College in 2004. Dr. Bellapianta holds New Jersey license 25MA09538900.

Dr. Bellapianta's primary practice is Bellapianta Orthopaedics and Sports Medicine, at 120 Valley Rd, Montclair, NJ 07042 in Essex County. The practice phone is (201) 490-4333.

Dr. Bellapianta's primary practice is Bellapianta Orthopaedics and Sports Medicine in Montclair, New Jersey. Dr. Bellapianta is also affiliated with Hackensack Meridian Mountainside Medical Center. The medical group on file is Bellapianta Orthopaedics & Sports Medicine. Dmand AI also links Dr. Bellapianta to 3 more hospitals, 3 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bellapianta practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Bellapianta's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Bellapianta is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Bellapianta's licenses on file in 5 states: New Jersey, Florida, New York, Connecticut and Alabama.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, enthesopathy in arms, enthesopathy in foot or ankle, hand joint or tendon inflammation, hip replacement and joint pain among the conditions Dr. Bellapianta treats.

CMS data shows 24,676 Medicare services from Dr. Bellapianta across 22 procedure codes in 2024, for 434 Medicare patients. Medicare paid $219,791 for them.

CMS counts 434 Medicare patients who saw Dr. Bellapianta in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have arthritis, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bellapianta's median patient age at 62, with 51% women.

In 2024, Dr. Bellapianta wrote 564 Medicare Part D claims for 198 patients. 95% of them were for generic drugs. CMS names the drug for 507 of them, across 17 drugs with 11 or more claims each, at $25,476 in total drug cost. In 2023, CMS named 441 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 24 out of 100 for Dr. Bellapianta for performance year 2024, reported individually. Dr. Bellapianta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Bellapianta, more than 78% of the clinicians it reports for that procedure.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Bellapianta in 2011. 2011 was the busiest year, with 2. The most frequent topics are Tomography, X-Ray Computed. Dr. Bellapianta has published most often in J Orthop Trauma. Dr. Bellapianta's most frequent co-authors are Jordan M. Lisella, MD, James R. Andrews, MD and John Czajka, MD.

CMS Open Payments shows 185 general payments to Dr. Bellapianta from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Smith & Nephew, Inc. paid the most, $54,286.

Dr. Bellapianta graduated from Albany Medical College in 2004.

Dr. Bellapianta is in network with 2 carriers, including Elevance and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.